thelancet.com
Jun 12, 2025, 05:36
The Lancet Haematology – Extended Anticoagulation in Children with VTE: New Insights from the EINSTEIN-Jr Trial
The Lancet Haematology shared on X:
“A cohort study within the EINSTEIN-Jr trial explores extended-phase anticoagulation for acute VTE in children:
Key factors: symptomatic index VTE, unprovoked VTE, & residual thrombosis.
Low risk of recurrent VTE & no major bleeding.”
Title: Extended-phase anticoagulant treatment of acute venous thromboembolism in children: a cohort study from the EINSTEIN-Jr phase 3 trial.
Autors: Christoph Male, Anthonie W A Lensing, Anthony K C Chan, Gili Kenet, Guy Young, Rukhmi Bhat, Akos F Pap, Dagmar Kubitza, Martin H Prins, Paul Monagle.
Here are some of the most compelling recent updates on Hemostasis Today
Akos F Pap
Anthonie W A Lensing
Anthony K C Chan
Anticoagulation Safety
Bleeding Risk in Children
Christoph Male
Dagmar Kubitza
EINSTEIN-Jr Trial
Extended-phase Anticoagulation
Gili Kenet
Guy Young
Hemostasis Today
Martin H Prins
Paul Monagle
Pediatric Hemostasis
Pediatric Venous Thromboembolism
Recurrent Thrombosis Risk
Residual Thrombosis
Rukhmi Bhat
Symptomatic VTE
The Lancet Haematology
Unprovoked VTE in Children
-
Jun 12, 2025, 10:34Apply Now: HTRS Funding Opportunities for Aspiring Hemostasis Researchers
-
Jun 12, 2025, 10:33Review of Factor IX Replacement Therapy in Hemophilia B with CSL Behring on June 22
-
Jun 12, 2025, 10:30Dr. Laura Girardi Awarded 2025 Thrombosis Canada – CanVECTOR Research Fellowship
-
Jun 12, 2025, 10:21Elevate Your Career: American Society of Hematology Clinical Research Training Institute in the Mediterranean, Middle East, and North Africa
-
Jun 12, 2025, 07:45Richard Kelly - Is it possible to discontinue anticoagulation in patients with PNH?
-
Jun 12, 2025, 06:59DOACs vs. Warfarin in Cerebral Venous Thrombosis: ACTION-CVT Study Shows Safer Profile Without Compromising Efficacy
-
Jun 8, 2025, 14:49Shematologist Highlights Iron Deficiency's Impact on Mental Health in Young Females
-
Jun 7, 2025, 10:28IL-10 From Tumoral B Cells Modulates the Diffuse Large B-Cell Lymphoma Microenvironment and Response to Immunotherapy
-
Jun 7, 2025, 08:46David Smadja: A Major Step Forward in The Fight Against Cancer-Related Thrombosis
-
Jun 6, 2025, 15:52Long-term Efficacy and Safety of Mitapivat in Non-Transfusion-Dependent α- or β-thalassaemia - British Journal of Haematology
-
Mar 6, 2025, 17:15Olympus Announces Launch of Single-Use Hemostasis Clip
-
Jun 11, 2025, 08:42Unmasking Thrombocytosis: What a High Platelet Count Really Means
-
Jun 7, 2025, 12:50ASH Sends a Letter to Senate Leaders Urging Them to Reject Harmful Medicaid Changes
-
Jun 7, 2025, 12:41ISTH - Abstracts for ISTH2025 are now LIVE
-
Jun 7, 2025, 12:29ASH - The Future of Classical Hematology is In Excellent Hands
-
Jun 7, 2025, 10:48Join Us For the Bleeding Disorders Conference 2025 - National Bleeding Disorders Foundation
Jun 12, 2025, 10:34
Jun 12, 2025, 07:27
Jun 12, 2025, 06:11
Jun 11, 2025, 10:21